VFA
BMRN icon

Voya Financial Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Voya Financial Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,595
Closed -$269K – 291
2021
Q1 		$269K Buy
3,595
+124
+4% +$10.1K 0.01% 566
2020
Q4 		$302K Sell
3,471
-70
-2% -$5.55K 0.01% 515
2020
Q3 		$269K Buy
3,541
+145
+4% +$14.7K 0.01% 499
2020
Q2 		$415K Buy
3,396
+45
+1% +$4.47K 0.02% 408
2020
Q1 		$276K Buy
+3,351
New +$289K 0.02% 460

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Voya Financial Advisors's BMRN Position: Q2 2021 in Review

Voya Financial Advisors sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2021, closing a stake of 3,595 shares — an estimated $269K sold.

Voya Financial Advisors first reported a position in BMRN in Q1 2020 and held it in 5 quarters. The position peaked at $415K in Q2 2020. 529 funds tracked by Wall St. Rank hold BMRN as of Q2 2021.

  • Voya Financial Advisors reported no remaining BioMarin Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Voya Financial Advisors sold 3,595 BioMarin Pharmaceuticals shares in Q2 2021, an estimated $269K.
  • Voya Financial Advisors first reported a position in BioMarin Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • Voya Financial Advisors's BioMarin Pharmaceuticals position peaked at $415K in Q2 2020.
  • 529 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2021.

Based on Voya Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.